1.877.223.9977
Call Toll Free
 |
 |
 |
 |
 |
 |
 |
Join us on FaceBook
bigmountaindrugs
Like it, tweet it!
bigmountaindrug
Enjoy Youtube bigmountaindrug
Subscribe to
RSS feed
domperidone fda
Even though the FDA’s own division of gastrointestinal medications approved domperidone, and numerous U.S. clinical drug trials have demonstrated domperidone’s safety and effectiveness in dealing with gastroparesis (delayed stomach emptying) symptoms, the FDA has turned down the medication manufacturer Janssen Pharmaceutical’s application for approval.
(more…)
Dogs in Glaucoma
Glaucoma in Dogs
The same prescription medication used to treat glaucoma in humans, Xalatan eye drops (also marketed as generic latanoprost), is used to treat glaucoma in dogs. Latanoprost ophthalmic solution is not FDA approved to treat canine glaucoma, but can be legally prescribed off-label by a veterinarian. There are no veterinary formulations of latanoprost.
(more…)
Brilinta for ACS
Boxed warning says daily aspirin doses above 100 milligrams decrease effectiveness
The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).
ACS includes a group of symptoms for any condition, such as unstable angina or heart attack, that could result from reduced blood flow to the heart. Brilinta works by preventing the formation of new blood clots, thus maintaining blood flow in the body to help reduce the risk of another cardiovascular event.
(more…)
July 01, 2011 /FDA.gov/NewsEvents/ — FDA News Release. The U.S. Food and Drug Administration today approved Arcapta Neohaler (indacaterol inhalation powder) for the long term, once-daily maintenance bronchodilator treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema.
COPD is a serious lung disease that makes breathing difficult. Symptoms can include breathlessness, chronic cough and excessive phlegm. Cigarette smoking is the leading cause of COPD, and is the fourth leading cause of death in the United States, according to the Centers for Disease Control and Prevention.
(more…)
Hopital Formulary
RIDGEFIELD, Conn., July 21, 2011 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that Pradaxa (dabigatran etexilate mesylate) capsules has been added to hospital formularies at 49 of the top 50 cardiology and heart surgery hospitals, as ranked by U.S. News & World Report’s Best Hospitals 2011-2012, published online on July 19. PRADAXA is approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF).(1)
Atrial fibrillation (AFib), characterized by an irregular heartbeat,(2) increases the risk of stroke nearly five times.(3) Approximately 80 percent of U.S. adults living with AFib are age 65 or older,(4) and many have other conditions, such as diabetes or hypertension, that further increase the risk of stroke. (more…)
about gout medication
Gout medication falls into two categories – drugs to relieve the pain and inflammation of an attack, and preventive gout medicine to ward off future attacks and avoid complications.
(more…)
Diabetes and Gastroparesis
When the vagus nerve is damaged, food either moves too slowly through the digestive system, or doesn’t move at all. As a result, people with gastroparesis often feel bloated, feel full after eating a small amount, and may experience heartburn, stomach and abdominal pain, nausea and vomiting, loss of appetite, and acid reflux.
Gastroparesis is a vicious cycle for a diabetic. Not only does uncontrolled blood sugar lead to gastroparesis, gastroparesis leads to poor blood sugar control due to the irregular passage of food through the digestive system. When food is finally absorbed, blood sugar levels may rise unexpectedly.
(more…)
In the public uproar over the massive increase in the price of the gout medication colchicine following the FDA-ordered removal of generic versions of the gout drug from the American market, many have lost sight of two significant FDA findings.
Concerned that older drugs that have been in use since before the inception of a stringent approval process in the 1960′s may not meet current standards for safety, effectiveness, quality and labeling, the FDA launched the Unapproved Drug Initiative in 2006.
Pharmaceutical companies manufacturing older, unapproved medications were expected to put them through expensive clinical trials to win formal FDA approval. In return, the companies would be given exclusive market rights for a specified time period to allow them to recoup their investment.
(more…)
Omega-3 fatty acids from fish have long been touted as natural blood thinners that discourage clotting. Now European researchers are recommending patients with stents in their arteries take omega-3s along with their prescription blood thinners to reduce the risk of heart attack.
Heart patients who’ve had stents implanted to keep their arteries open are being advised to add omega-3 fatty acids to their blood thinning medication. Omega-3 fatty acids have long been thought to help reduce the risk of heart problems in people with coronary artery disease, but a recent European study is believed to be the first to examine the effect of taking omega-3s along with blood thinners, or anti-platelet medication.
(more…)
It seems as if every other commercial on television is for some new medication invented to deal with one of the many ailments that come with being human.
Recently I noted two different medications with names that elude me. That’s one of the problems with this new development — our consciousnesses become glutted with many new names until they all bleed together.
These two medications supposedly treat problems that could possibly be basic human weaknesses — restless leg syndrome and dry eye. Although they are classified as medical conditions, please forgive my lack of empathy. It just seems as if some things are more inconveniences than disease.
(more…)